Liver Diseases. Yasmine Lashine MD, PhD

Similar documents
Liver Failure. The most severe clinical consequence of liver disease is liver failure:

Liver failure &portal hypertension

CHAPTER 1. Alcoholic Liver Disease

Approach to the Patient with Liver Disease

LIVER DISEASES. Pathology Department, Zhejiang University School of Medicine,

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

Disorders of the Liver, Gallbladder and Pancreas

Workup of a Solid Liver Lesion

Liver, Pancreas and Gall Bladder Pathology

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

Jaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD

Gastrointestinal System: Accessory Organ Disorders

World Health Organization. Western Pacific Region

Management of Hepatitis C in Primary Care BABAFEMI ONABANJO, MD & BEN ALFRED, FNP UMASS FAMILY HEALTH CENTER WORCESTER

Pathology of the Liver and Biliary Tract 1 Normal Liver; Hepatic Injury, Response, and Failure

Function: 1-Metabolic : Glucose. factors.. 3-Detoxification : Drugs, hormones, NH3. : Glycogen, TG, Fe, Cu, vit. 5-Excretory : Bile

CrackCast Episode 28 Jaundice

Definition: fibrosis and nodular regeneration resulting from hepatocellular injury

Podcast (Video Recorded Lecture Series): Portal HTN and Derivatives for the USMLE Step One Exam. Ultrasound (w/ doppler) Reversal of flow Portal Vein

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

Denver Shunts vs TIPS for Ascites

Tumor incidence varies significantly, depending on geographical location.

Chief Complain. Liver lesion found in routine health check 41 days ago

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

Hepatitis. Dr. Mohamed. A. Mahdi 5/2/2019. Mob:

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

PORTAL HYPERTENSION. Tianjin Medical University LIU JIAN

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

Understanding this condition will help you provide optimal care for patients and their families.

Histology. The pathology of the. bile ducts. pancreas. liver. The lecture in summary. Vt-2006

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV

)Liver diseases I and II)

Tranjugular Intrahepatic Portosystemic Shunt

What is Liver Cancer? About the Liver

EDEMA. Basic Course of Diagnosis

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

Cross section of normal liver

Gastrointes*nal and Liver Pathology. Kris*ne Kra5s, M.D.

Supplementary Digital Content

Disorders of the Liver and Pancreas

Karen A. Hicks, M.D. Medical Officer Division of Cardiovascular and Renal Products Center for Drug Evaluation and Research, FDA

Index. Note: Page numbers of article titles are in boldface type.

Hepatocellular Carcinoma HCC Updated November 2015 by: Dr. Mohammed Alghamdi (Medical Oncology Fellow, University of Calgary)

Natural history of α-1-atd in children

Jesse Civan, M.D. Medical Director, Jefferson Liver Tumor Center

Hepatocellular Carcinoma (HCC)

Hepatitis Panel/Acute Hepatitis Panel

Etiology of liver cirrhosis

Conflict of interest disclosures. Complications of end stage liver disease. None. The many complications of Cirrhosis. Portal Hypertension.

הצגת מקרה- מפגש מכונים מאי 2017

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

Noncirrhotic Portal Hypertension and Pathology of the Sinusoids. Ian R. Wanless Department of Pathology Dalhousie University Halifax, Canada

Supplemental Tables. Parasitic Schistosomiasis increase < 1. Genetic Hemochromatosis increase < 1. autoimmune Autoimmune hepatitis (AIH) increase < 1

Detection and Characterization of Hepatocellular Carcinoma by Imaging

following the last documented transfusion; thereafter, evaluate the residual impairment(s).

Hepatitis Panel/Acute Hepatitis Panel

Resident Teaching Conference:

PORTAL HYPERTENSION An Introduction to the Culprit of Many Liver Failure Complications

Liver Cancer: Epidemiology and Health Disparities. Andrea Goldstein NP, MS, MPH Scientific Director Onyx Pharmaceuticals

Liver Cancer Causes, Risk Factors, and Prevention

Liver Tumors. Prof. Dr. Ahmed El - Samongy

Alpha-1 Antitrypsin Deficiency: Liver Disease

Viral hepatitis Blood Born hepatitis. Dr. MONA BADR Assistant Professor College of Medicine & KKUH

IS THERE A DIFFERENCE IN LIVER CANCER RATES IN PATIENTS WHO RECEIVE TREATMENT FOR HEPATITIS?

Gastroenterology. Certification Examination Blueprint. Purpose of the exam

Index. Note: Page numbers of article titles are in boldface type.

EVALUATION OF ABNORMAL LIVER TESTS

LIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly

بسم الله الرحمن الرحيم أوتيتم من العلم إال قليال وما

Hepatology Clinical presentation of liver disease. Hepatomegaly

Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC

Investigating the patient with ascites

Hepatocellular Carcinoma (HCC): Burden of Disease

Chapter 18 LIVER BILIARY TRACT

Clinical Trials & Endpoints in NASH Cirrhosis

How to Approach a Medical Liver Biopsy. 9 th Bryan Warren School of Pathology Pancreatic and Liver Pathology. Sarajevo, 6 th -7 th November 2015

Complications of Cirrhosis

Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology

Non-Cirrhotic Portal Hypertension and Incomplete Septal Cirrhosis. Stefan Hübscher, University of Birmingham, Birmingham B15 2TT, U.K.

The focus of this week s lab will be pathology of the gastrointestinal and hepatobiliary systems.

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust

PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES I HAVE NOTHING TO DISCLOSE CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017

End-Stage Liver Disease (ESLD): A Guide for HIV Physicians

Ontario s Adult Referral and Listing Criteria for Liver Transplantation

Hepatic Encephalopathy

Evaluation of Diffuse Liver Diseases Using Conventional Ultrasound

Cirrhosis of the Liver

Pathology of The Liver - Practice. 2017/ semester

AMR in Liver Transplantation: Incidence

Liver Disease. By: Michael Martins

2017/04/21 R1 歐宗頴. Case Discussion

Central role: - Regulating the immune system - Influencing metabolic and endocrine functions

British Liver Transplant Group Pathology meeting September Leeds cases

PROGRAMME AT A GLANCE

ESLD a Guide for HIV Physicians. Marion Peters University of California San Francisco June 2015

Transcription:

Liver Diseases Yasmine Lashine MD, PhD

ILOs Recognize different causes of Live failure Recall and understand clinical picture and complication of Liver failure Discuss causes and clinical picture of hepatic encephalopathy Discuss Liver cirrhosis in terms of, etiology morphology, pathogenesis and complication. Discuss and understand portal hypertension in terms of etiologic factors, pathogenesis clinical features, and course. Understand and recall Hepatocellular Carcinomas in terms of epidemiology, etiology, pathogenesis, clinical pictures and diagnostic tools

Outline I. Hepatic Failure II. Jaundice and Cholestasis III. Hepatic Encephalopathy IV. Cirrhosis V. Portal Hypertension VI. Portosystemic Shunt VII. Hepatocellular Carcinomas 3

Overview http://www.arizonatransplant.com/images/liver_large_1.jpg 4

Overview The liver contains ~1,000,000 lobules 5

Laboratory Evaluation of Liver Disease *The most commonly performed tests are in italics. Liver biopsy representing the gold standard for diagnosis 6

Hepatic Failure Hepatic failure occurs when 80% to 90% of hepatic function are lost. Acute liver failure with massive hepatic necrosis Uncommon Progresses to hepatic encephalopathy in 2-3 weeks Massive hepatic necrosis. Fetal and requires hepatic transplantation Chronic liver disease Most common Occurs due to chronic damage to the liver which often ends in cirrhosis Hepatic dysfunction without overt necrosis Less common Viable Hepatocytes but unable to perform their function acute fatty liver of pregnancy, and some drug- or toxinmediated injuries. 7

Hepatic Failure Clinical Features: Chronic liver faliure Jaundice/icterus (bilirubin >2.0 mg/dl) Hypoalbuminemia Hyperammonemia Palmar erythema Spider angiomas Hyperestrogenemia Acute liver failure Jaundice Encephalopathy 40% recover spontanously Spider angiomas Jaundice Palmer Erythema 8

Clinical consequences Hepatic Failure Hyperammonemia Hyperestrogenemia Hypoalbuminemia Coagulopathy Coma Fetor hepaticus Liver flap Asterixis Palmar erythema Spider angiomas Testicular atrophy Gynecomastia Ascitis Ascites Ankle edema Edema acut fatty liver pregn soe drugor toxinedinjuries. Bleeding tendency Ecchymoses Anemia

Hepatic Failure 10

Complications of Liver Failure Coagulopathy Respiratory failure Hepatic encephalopathy Renal failure

Hepatic Encephalopathy Hepatic encephalopathy may develop rapidly in acute liver failure or insidiously with gradually evolving chronic liver failure. Two factors seem to be important in the genesis of this disorder: Severe loss of hepatocellular function Shunting of blood from portal to systemic circulation Hepatic encephalopathy occurs due to: Elevation in blood ammonia impairs neuronal function and promotes generalized brain edema in acute liver failure (e.g. Acute hepatitis B infection) Deranged neurotransmitters production such as GABA (γaminobutyric acid ) leading to neuronal dysfunction in case of chronic liver failure (e.g. hepatic cirrhosis ).

13

Hepatic Encephalopathy Clinical manifestation : Brain dysfunction: Behavioral abnormalities Marked confusion Stupor, Deep coma and Death. Neurologic signs : Rigidity, hyperrfelexia and seizures Asterixis (flapping tremor) Nonrhythmic, rapid extensionflexion movements of the head and extremities, best seen when the arms are held in extension with dorsiflexed wrists.

Cirrhosis Cirrhosis is defined as a diffuse process characterized by fibrosis and the conversion of normal liver architecture into structurally abnormal nodules. Causes of Cirrhosis : Chronic viral infections Alcoholic or nonalcoholic steatohepatitis (NASH) Autoimmune diseases affecting hepatocytes and/or bile ducts

The three main characteristics of cirrhosis are (1) Involvement of most or all of the liver (2) Bridging fibrous septa (3) Parenchymal nodules containing a mix of senescent and replicating (often stem/progenitor cell-derived) hepatocytes. 16

Clinical features: Cirrhosis clinically silent nonspecific symptoms as : anorexia, weight loss and weakness. Hepatic failure mainfestions Clinical outcome : liver failure portal hypertension hepatocellular carcinoma 17

Portal Hypertension 18

Portal Hypertension http://baby--care.blogspot.com/2014/08/portal-hypertension-treatment.html#!/2014/08/portalhypertension-treatment.html 19

Portal Hypertension Causes: Prehepatic: congenital stenosis of PV, PV thrombosis (malignancy, hypercoagulable states, pancreatitis), extrinsic compression (tumors). Intrahepatic: cirrhosis, chronic hepatitis, schistosomiasis, massive fatty change, diffuse granulomatous diseases. Posthepatic: hepatic vein obstruction, constrictive pericarditis, right heart failure. The dominant intrahepatic cause is cirrhosis, accounting for most cases of portal hypertension. 20

Portal Hypertension Pathogenesis: Increased resistance to portal flow at the level of the sinusoids. Compression of central veins by perivenular fibrosis. Expanded parenchymal nodules. Hyperdynamic splanchnic circulation leading to an increase in portal venous blood flow (increased production of NO due to intrahepatic shunting of blood from portal to systemic circulation). 21

Ascites: Portal Hypertension Ascites is defines ad fluid collection in the peritoneal cavity. clinically detectable when at least 500 ml have accumulated. Turbid ascetic fluid due to Influx of neutrophils is due to secondary infection Bloody ascetic fluid is associated with intra-abdominal cancer. long-standing ascites, leads to passage of peritoneal fluid through transdiaphragmatic lymphatics leading to hydrothorax, more often on the right side. 22

Portal Hypertension Pathogenesis of Ascites: Increased movement of intravascular fluid into the extravascular space due to sinusoidal hypertension and hypoalbuminemia. Renal retention of sodium and water due to secondary hyperaldosteronism (decreased renal blood flow following decreased plasma volume) 23

Portal Hypertension Porto systemic shunts Abdominal wall collaterals Esophagogastric varices Hemorrhoid caput medusa Hematemesis Melena

Portal Hypertension caput medusae

Hepatocellular Carcinomas Epidemiology : Worldwide, HCC accounts for approximately 5.4% of all cancers. More than 85% of cases occur in countries with high rates of chronic HBV infection: Asian countries (southeast China, Korea, Taiwan) and sub-saharan African countries in which HBV is transmitted vertically. Moreover, many of these populations are exposed to aflatoxin, which when combined with HBV infection increases the risk of HCC dramatically. The peak incidence of HCC in these areas is between 20 and 40 years of age, and in almost 50% of cases, the tumor appears in the absence of cirrhosis. In Western countries the incidence of HCC is rapidly increasing, largely owing to the hepatitis C infection. 26

Hepatocellular Carcinomas Pathogenesis : Three major etiologic associations have been established: infection with HBV or HCV, alcoholic cirrhosis, and aflatoxin exposure. In many parts of the world, including Japan and Central Europe, chronic HCV infection is the most important risk factor in the development of liver cancer. In certain regions of the world, such as China and southern Africa, especially Mozambique, where HBV is endemic, high-level exposure to dietary aflatoxins derived from the fungus Aspergillus lavus is common. These carcinogenic toxins are found in moldy grains and peanuts. Aflatoxin can bind covalently with cellular DNA, resulting in mutations in genes such as TP53. 27

Hepatocellular Carcinomas Pathogenesis : In most cases, it develops from small-cell, high-grade dysplastic nodules in cirrhotic livers. Distinguishing high-grade dysplastic nodules from early HCC is difficult even in biopsies, because there are no molecular markers specific for these stages. Nodule vascularization, visualized by imaging, which is almost always a clear indication of malignancy. The presence of structural and numeric chromosomal abnormalities is a universal feature of HCC and are indicative of genomic instability. 28

Hepatocellular Carcinomas Morphology : HCC may appear grossly as A unifocal, usually massive tumor. A multifocal tumor made of nodules of variable size. A diffusely infiltrative cancer, permeating widely and sometimes involving the entire liver. On histologic examination: HCCs range from well differentiated lesions to poorly differentiated lesions, often composed of large, multinucleate anaplastic giant cells. There is little stroma in most hepatocellular carcinomas, explaining their soft consistency. 29

Hepatocellular Carcinomas Clinical Features : Although HCC may manifest with silent hepatomegaly, it is more often encountered in persons with symptomatic cirrhosis of the liver. In these persons, the following features call attention to the development of a tumor: A rapid increase in liver size A sudden worsening of ascites The appearance of bloody ascites Fever Pain 30

Hepatocellular Carcinomas Clinical Features : The most commonly used marker is serum alpha-fetoprotein level, but it rises only with advanced tumors and only in 50% of patients. Many non-neoplastic conditions lead to an increased level of AFP such as cirrhosis, chronic hepatitis, normal pregnancy, and massive liver necrosis. Alpha-fetoprotein level is neither specific nor sensitive. Radiologic screening of patients with cirrhosis at 6-month intervals, looking for dysplastic nodules or early, small HCC, is the current clinical frontier. 31

References ROBBINS Basic Pathology 9 th Edition Source of the cover: http://www.dietdoctor.com/restoring-liver-function-lchf 32

Thank you 33

Palmer Erythema Spider Navi Caput mudosa

35